Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nektar Therapeutics (NKTR)
NASDAQ:NKTR
Holding NKTR?
Track your performance easily
Nektar Therapeutics (NKTR) Ownership Overview
10.79% Insiders
19.37% Mutual Funds
35.49% Other Institutional Investors
10.74% ETFs
23.61% Public Companies and
Individual Investors
The ownership structure of Nektar Therapeutics (NKTR) stock is a mix of institutional, retail, and individual investors. Approximately 65.60% of the company’s stock is owned by Institutional Investors, 10.79% is owned by Insiders, and 23.61% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 20, 2024 | Howard Robin President & Ceo,director | xxxxxxxxxxxxx | $16441 |
| Nov 20, 2024 | Jonathan Zalevsky Chief R&d Officer | xxxxxxxxxxxxx | $7863 |
| Aug 20, 2024 | Howard Robin President & Ceo,director | xxxxxxxxxxxxx | $19048 |
| Aug 20, 2024 | Jonathan Zalevsky Chief R&d Officer | xxxxxxxxxxxxx | $8788 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $24774 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $2251172 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $7686188 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 18,344,000 | Insider | 9.94% | 18,527,440 | |
| 9,902,961 | Institution | 5.37% | 10,001,991 | |
| 9,400,000 | Institution | 5.10% | 9,494,000 | |
| 8,643,101 | Institution | 4.69% | 8,729,532 | |
| 7,609,067 | Institution | 4.13% | 7,685,158 | |
| 5,912,453 | Institution | 3.21% | 5,971,578 | |
| 5,390,942 | Institution | 2.92% | 5,444,851 | |
| 2,280,412 | Institution | 1.24% | 2,303,216 | |
| 2,083,893 | Institution | 1.13% | 2,104,732 | |
| 1,731,671 | Institution | 0.94% | 1,748,988 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,400,000 | Institution | 5.10% | 9,494,000 | |
| 8,643,101 | Institution | 4.69% | 8,729,532 | |
| 5,390,942 | Institution | 2.92% | 5,444,851 | |
| 2,280,412 | Institution | 1.24% | 2,303,216 | |
| 2,083,893 | Institution | 1.13% | 2,104,732 | |
| 1,614,640 | Institution | 0.88% | 1,630,786 | |
| 1,362,100 | Institution | 0.74% | 1,375,721 | |
| 1,001,660 | Institution | 0.54% | 1,011,677 | |
| 854,274 | Institution | 0.46% | 862,817 | |
| 568,896 | Institution | 0.31% | 574,585 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,724,732 | Institution | 3.10% | 6,812,431 | |
| 5,375,599 | Institution | 2.91% | 5,429,355 | |
| 2,662,436 | Institution | 1.44% | 3,168,299 | |
| 1,811,986 | Institution | 0.98% | 1,830,106 | |
| 813,839 | Institution | 0.44% | 968,468 | |
| 790,048 | Institution | 0.43% | 790,048 | |
| 565,829 | Institution | 0.31% | 673,337 | |
| 530,860 | Institution | 0.29% | 536,169 | |
| 421,482 | Institution | 0.23% | 425,697 | |
| 176,682 | Institution | 0.10% | 176,682 |
FAQ
Who Owns Nektar Therapeutics (NKTR)?
According to the latest TipRanks data, approximately 35.49% of the company's stock is held by institutional investors, 10.79% is held by insiders, and 23.61% is held by retail investors.
What percentage of Nektar Therapeutics (NKTR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 35.49% of Nektar Therapeutics (NKTR) stock is held by institutional investors.
What percentage of Nektar Therapeutics (NKTR) stock is held by retail investors?
According to the latest TipRanks data, approximately 23.61% of Nektar Therapeutics (NKTR) stock is held by retail investors.
Who owns the most shares of Nektar Therapeutics (NKTR)?
Deep Track Capital, LP owns the most shares of Nektar Therapeutics (NKTR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.